ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,564.41
1.08%
US Tech 100
19,270.40
-0.18%
Dow Jones
40,421.36
0.33%
Brent Oil
81.49
-0.03%
Bitcoin
66,710.52
-1.32%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. GRI Bio Inc (GRI)

  7. GRI Bio Inc (GRI) News

GRI

GRI Bio (GRI)

GRI Bio Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:GRI
DateTimeSourceHeadlineSymbolCompany
07/15/20249:05AMGlobeNewswire Inc.GRI Bio (NASDAQ: GRI) to Participate in the Virtual Investor Lunch Break SeriesNASDAQ:GRIGRI Bio Inc
07/11/20249:20AMGlobeNewswire Inc.GRI Bio (NASDAQ: GRI) Participates in Virtual Investor “What This Means” SegmentNASDAQ:GRIGRI Bio Inc
07/08/20249:05AMGlobeNewswire Inc.GRI Bio Regains Compliance with NasdaqNASDAQ:GRIGRI Bio Inc
07/02/20249:05AMGlobeNewswire Inc.GRI Bio Announces Publication of Positive Preclinical Data from Lead Program GRI-0621 in the American Journal of Respiratory and Critical Care MedicineNASDAQ:GRIGRI Bio Inc
07/01/20248:45AMGlobeNewswire Inc.GRI Bio to Present at the 8th Annual IPF SummitNASDAQ:GRIGRI Bio Inc
06/28/20244:05PMGlobeNewswire Inc.GRI Bio Announces Closing of $4.0 Million Public OfferingNASDAQ:GRIGRI Bio Inc
06/27/20249:00AMGlobeNewswire Inc.GRI Bio Announces Korea Patent Granted for Proprietary Natural Killer T (NKT) Cell ModulatorsNASDAQ:GRIGRI Bio Inc
06/27/20248:00AMGlobeNewswire Inc.GRI Bio Announces Pricing of $4 Million Public OfferingNASDAQ:GRIGRI Bio Inc
06/14/20248:05AMGlobeNewswire Inc.GRI Bio Announces Reverse Stock SplitNASDAQ:GRIGRI Bio Inc
06/11/20249:00AMGlobeNewswire Inc.GRI Bio (NASDAQ: GRI) to Present at the Virtual Investor Pitch ConferenceNASDAQ:GRIGRI Bio Inc
05/22/20249:15AMGlobeNewswire Inc.GRI Bio (NASDAQ: GRI) Participates in Virtual Investor “What This Means” Segment Highlighting Positive Preclinical Data from Idiopathic Pulmonary Fibrosis (IPF) and Systemic Lupus Erythematosus (SLE) ProgramsNASDAQ:GRIGRI Bio Inc
05/21/20248:35AMGlobeNewswire Inc.GRI Bio Presents Positive Preclinical Data from Pipeline of NKT Cell Modulators in Development for the Treatment of Systemic Lupus Erythematosus (SLE)NASDAQ:GRIGRI Bio Inc
05/20/20248:45AMGlobeNewswire Inc.GRI Bio Presents Positive Preclinical Data Demonstrating Lead Program GRI-0621 Reduces the Important Inflammatory and Fibrotic Drivers in Idiopathic Pulmonary Fibrosis (IPF)NASDAQ:GRIGRI Bio Inc
05/14/20249:05AMGlobeNewswire Inc.GRI Bio to Present at Alliance Global Partner’s 2024 Healthcare Company ShowcaseNASDAQ:GRIGRI Bio Inc
05/13/20248:00AMGlobeNewswire Inc.GRI Bio Reports First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:GRIGRI Bio Inc
04/29/20248:45AMGlobeNewswire Inc.GRI Bio Announces Abstracts Accepted for Presentation at the 14th International Congress on AutoimmunityNASDAQ:GRIGRI Bio Inc
04/25/20249:15AMGlobeNewswire Inc.GRI Bio to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment WebinarNASDAQ:GRIGRI Bio Inc
04/16/20248:35AMGlobeNewswire Inc.GRI Bio Expands Intellectual Property Protection for Proprietary Natural Killer T (NKT) Cell Modulators with Issuance of Korea PatentNASDAQ:GRIGRI Bio Inc
04/08/20248:35AMGlobeNewswire Inc.GRI Bio Announces Abstract Accepted for Poster Presentation at the 2024 American Thoracic Society International ConferenceNASDAQ:GRIGRI Bio Inc
04/01/20247:35AMGlobeNewswire Inc.GRI Bio Reports Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:GRIGRI Bio Inc
03/28/20249:00AMGlobeNewswire Inc.GRI Bio to Present at the MedInvest Biotech & Pharma Investor ConferenceNASDAQ:GRIGRI Bio Inc
03/14/20248:45AMGlobeNewswire Inc.GRI Bio Announces Notice of Allowance for Canadian Patent Covering Proprietary Natural Killer T (NKT) Cell ModulatorsNASDAQ:GRIGRI Bio Inc
03/04/20248:30AMGlobeNewswire Inc.GRI Bio Receives MHRA Authorization to Conduct Phase 2a Biomarker Study Evaluating GRI-0621 in the United KingdomNASDAQ:GRIGRI Bio Inc
02/02/20248:00AMGlobeNewswire Inc.GRI Bio Announces Pricing of $5.5 Million Public OfferingNASDAQ:GRIGRI Bio Inc
01/26/20248:05AMGlobeNewswire Inc.GRI Bio Announces Reverse Stock SplitNASDAQ:GRIGRI Bio Inc
12/05/20239:05AMGlobeNewswire Inc.GRI Bio Commences Patient Enrollment in Phase 2a Biomarker Study Evaluating Lead Program GRI-0621 for the Treatment of Idiopathic Pulmonary Fibrosis (“IPF”)NASDAQ:GRIGRI Bio Inc
11/27/20238:35AMGlobeNewswire Inc.GRI Bio (NASDAQ: GRI) Announces FDA Clearance of IND for Lead Program GRI-0621, a Type 1 Invariant NKT (“iNKT”) Antagonist for the Treatment of Idiopathic Pulmonary Fibrosis (“IPF”)NASDAQ:GRIGRI Bio Inc
11/15/20238:05AMGlobeNewswire Inc.GRI Bio (NASDAQ: GRI) Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:GRIGRI Bio Inc
10/31/20238:45AMGlobeNewswire Inc.GRI Bio Presents Data Supporting Innovative Pipeline of NKT Cell Modulators for the Treatment of High-Value Inflammatory, Fibrotic and Autoimmune DiseasesNASDAQ:GRIGRI Bio Inc
10/19/20238:45AMGlobeNewswire Inc.GRI Bio Presents Translational Data Demonstrating Connection Between NKT Cells and the Pathogenesis of Idiopathic Pulmonary Fibrosis (IPF) at the 2023 Pittsburgh-Ireland International Lung ConferenceNASDAQ:GRIGRI Bio Inc
 Showing the most relevant articles for your search:NASDAQ:GRI

Your Recent History

USOTC
ITUP
Interups (CE)
USOTC
IDVV
International Endeavors (PK)
NYSE
AMC
AMC Entertainment
USOTC
MGON
Megola (PK)
USOTC
AABB
Asia Broadband (PK)
USOTC
GRLT
Grillit (PK)
USOTC
SHMP
NaturalShrimp (QB)
USOTC
ECSL
Ecare Solutions (PK)
USOTC
CNNA
Cann American (CE)
USOTC
NBRI
North Bay Resources (PK)
NASDAQ
LWLG
Lightwave Logic
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
HIRU
Hiru (PK)
USOTC
CGAC
Code Green Apparel (PK)
USOTC
FNMA
Fannie Mae (QB)
USOTC
ELTP
Elite Pharmaceuticals (QB)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved